M S, S S
Adv Pharmacol Pharm Sci. 2025; 2024():5248746.
PMID: 39781028
PMC: 11707065.
DOI: 10.1155/2024/5248746.
Mohammad S, Aldosari B, Mehanni M, El-Gendy A, Hozayen W, Afzal O
Int J Pharm X. 2024; 7:100247.
PMID: 38706465
PMC: 11066576.
DOI: 10.1016/j.ijpx.2024.100247.
Paudwal G, Dolkar R, Perveen S, Sharma R, Pal Singh P, Gupta P
AAPS J. 2024; 26(3):52.
PMID: 38649550
DOI: 10.1208/s12248-024-00922-w.
Li J, Long Q, Ding H, Wang Y, Luo D, Li Z
Adv Sci (Weinh). 2024; 11(16):e2308677.
PMID: 38419366
PMC: 11040388.
DOI: 10.1002/advs.202308677.
Hakim Ramadan A, Elsayed M, Elsayed A, Fouad M, Mohamed M, Lee S
Int J Pharm X. 2024; 7:100232.
PMID: 38357578
PMC: 10864762.
DOI: 10.1016/j.ijpx.2024.100232.
Development and Characterization of Pentaerythritol-EudragitRS100 Co-processed Excipients as Solid Dispersion Carriers for Enhanced Aqueous Solubility, Dissolution, and Permeation of Atorvastatin.
R Telange D, Bhaktani N, Hemke A, Pethe A, Agrawal S, Rarokar N
ACS Omega. 2023; 8(28):25195-25208.
PMID: 37483203
PMC: 10357539.
DOI: 10.1021/acsomega.3c02280.
Several Applications of Solid Lipid Nanoparticles in Drug Delivery.
Khil N, Sharma S, Sharma P, Alam A
Curr Mol Med. 2023; 24(9):1077-1090.
PMID: 37475554
DOI: 10.2174/1566524023666230720110351.
Biological evaluation of novel gemcitabine analog in patient-derived xenograft models of pancreatic cancer.
Inkoom A, Ndemazie N, Smith T, Frimpong E, Bulusu R, Poku R
BMC Cancer. 2023; 23(1):435.
PMID: 37179357
PMC: 10182601.
DOI: 10.1186/s12885-023-10928-w.
Solid Lipid Nanoparticles: Applications and Prospects in Cancer Treatment.
Sivadasan D, Ramakrishnan K, Mahendran J, Ranganathan H, Karuppaiah A, Rahman H
Int J Mol Sci. 2023; 24(7).
PMID: 37047172
PMC: 10094605.
DOI: 10.3390/ijms24076199.
The Usefulness of Nanotechnology in Improving the Prognosis of Lung Cancer.
Bordeianu G, Filip N, Cernomaz A, Veliceasa B, Hurjui L, Pinzariu A
Biomedicines. 2023; 11(3).
PMID: 36979684
PMC: 10045176.
DOI: 10.3390/biomedicines11030705.
Current Advances in Lipid Nanosystems Intended for Topical and Transdermal Drug Delivery Applications.
Akombaetwa N, Ilangala A, Thom L, Memvanga P, Witika B, Buya A
Pharmaceutics. 2023; 15(2).
PMID: 36839978
PMC: 9967415.
DOI: 10.3390/pharmaceutics15020656.
Compritol-Based Alprazolam Solid Lipid Nanoparticles for Sustained Release of Alprazolam: Preparation by Hot Melt Encapsulation.
Rao H, Ahmad S, Madni A, Rao I, Ghazwani M, Hani U
Molecules. 2022; 27(24).
PMID: 36558027
PMC: 9783086.
DOI: 10.3390/molecules27248894.
Quality by Design Based Formulation of Xanthohumol Loaded Solid Lipid Nanoparticles with Improved Bioavailability and Anticancer Effect against PC-3 Cells.
Harish V, Tewari D, Mohd S, Govindaiah P, Ravindra Babu M, Kumar R
Pharmaceutics. 2022; 14(11).
PMID: 36365221
PMC: 9699314.
DOI: 10.3390/pharmaceutics14112403.
Psychotropic drugs interaction with the lipid nanoparticle of COVID-19 mRNA therapeutics.
Sfera A, Hazan S, Anton J, Sfera D, Andronescu C, Sasannia S
Front Pharmacol. 2022; 13:995481.
PMID: 36160443
PMC: 9503827.
DOI: 10.3389/fphar.2022.995481.
Efficacy of Polymer-Based Nanomedicine for the Treatment of Brain Cancer.
Naki T, Aderibigbe B
Pharmaceutics. 2022; 14(5).
PMID: 35631634
PMC: 9145018.
DOI: 10.3390/pharmaceutics14051048.
A Recent Update: Solid Lipid Nanoparticles for Effective Drug Delivery.
Pandey S, Shaikh F, Gupta A, Tripathi P, Yadav J
Adv Pharm Bull. 2022; 12(1):17-33.
PMID: 35517874
PMC: 9012924.
DOI: 10.34172/apb.2022.007.
The Challenges and Opportunities in the Development of MicroRNA Therapeutics: A Multidisciplinary Viewpoint.
Momin M, Gaddam R, Kravitz M, Gupta A, Vikram A
Cells. 2021; 10(11).
PMID: 34831320
PMC: 8619171.
DOI: 10.3390/cells10113097.
Antitumoral Activities of Curcumin and Recent Advances to ImProve Its Oral Bioavailability.
Nocito M, De Luca A, Prestia F, Avena P, Padula D, Zavaglia L
Biomedicines. 2021; 9(10).
PMID: 34680593
PMC: 8533288.
DOI: 10.3390/biomedicines9101476.
Lipid nanostructures for targeting brain cancer.
Nsairat H, Khater D, Odeh F, Al-Adaileh F, Al-Taher S, Jaber A
Heliyon. 2021; 7(9):e07994.
PMID: 34632135
PMC: 8488847.
DOI: 10.1016/j.heliyon.2021.e07994.
Pharmaceutical and Pharmacological Evaluation of the Effect of Nano-Formulated Spironolactone and Progesterone on Inflammation and Hormonal Levels for Managing Hirsutism Experimentally Induced in Rats.
Amer R, Yassin G, Mohamed R, Fayez A
AAPS PharmSciTech. 2021; 22(5):204.
PMID: 34258696
DOI: 10.1208/s12249-021-02003-z.